Estrogen receptor-mediated processes in normal and cancer cells
- PMID: 10963625
- DOI: 10.1093/oxfordjournals.jncimonographs.a024237
Estrogen receptor-mediated processes in normal and cancer cells
Abstract
The role of estrogens in breast and other cancers has been extensively investigated for many years, and historically most of these studies have focused on the hormonal regulation of cell proliferation. The most recent work in this area has focused on the expression of genes likely to mediate proliferation (e.g., growth factors, proto-oncogenes, etc.) and their regulation by the classic nuclear estrogen receptor, ER-alpha. In this chapter, we present a synopsis of several new developments in this area of ER-regulated gene expression. These developments include the following: 1) the selective activation of ER domains by partial estrogen antagonists, such as tamoxifen and other ligands; 2) the effects of ER-alpha overexpression and gene knockout on the development of breast and uterine cancers in experimental animal models; 3) mechanisms by which steroid hormones regulate programmed cell death, cell cycle progression, cell-substratum interactions, and genomic instability in cancer cells; 4) identification of nuclear proteins that interact with the ER in the presence of agonists and antagonists, the effect of ligand binding on the receptor structure, and the interactions of liganded and nonliganded receptors with coactivators, corepressors, and other regulatory proteins; and 5) the biochemical properties, cellular distribution, and potential biologic roles for the newly discovered ER-beta. Although there is an increasing interest in understanding the role of estrogens as endogenous carcinogens, it remains clear that ER-mediated regulation of gene expression plays many significant roles in normal and cancer cells, and increased knowledge of the mechanisms involved will improve our overall understanding of hormonal carcinogenesis.
Similar articles
-
Estrogen receptors: selective ligands, partners, and distinctive pharmacology.Recent Prog Horm Res. 2000;55:163-93; discussion 194-5. Recent Prog Horm Res. 2000. PMID: 11036937 Review.
-
Expression levels of estrogen receptor-alpha, estrogen receptor-beta, coactivators, and corepressors in breast cancer.Clin Cancer Res. 2000 Feb;6(2):512-8. Clin Cancer Res. 2000. PMID: 10690532
-
Genes related to estrogen action in reproduction and breast cancer.Front Biosci. 2005 Sep 1;10:2346-72. doi: 10.2741/1703. Front Biosci. 2005. PMID: 15970500 Review.
-
Dominant-negative nuclear receptor corepressor relieves transcriptional inhibition of retinoic acid receptor but does not alter the agonist/antagonist activities of the tamoxifen-bound estrogen receptor.Mol Endocrinol. 2003 Aug;17(8):1543-54. doi: 10.1210/me.2001-0144. Epub 2003 May 1. Mol Endocrinol. 2003. PMID: 12730327
-
ER beta inhibits proliferation and invasion of breast cancer cells.Endocrinology. 2001 Sep;142(9):4120-30. doi: 10.1210/endo.142.9.8395. Endocrinology. 2001. PMID: 11517191 Free PMC article.
Cited by
-
Signaling within a coactivator complex: methylation of SRC-3/AIB1 is a molecular switch for complex disassembly.Mol Cell Biol. 2006 Nov;26(21):7846-57. doi: 10.1128/MCB.00568-06. Epub 2006 Aug 21. Mol Cell Biol. 2006. PMID: 16923966 Free PMC article.
-
Arsenic abrogates the estrogen-signaling pathway in the rat uterus.Reprod Biol Endocrinol. 2010 Jul 2;8:80. doi: 10.1186/1477-7827-8-80. Reprod Biol Endocrinol. 2010. PMID: 20598115 Free PMC article.
-
Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.Breast Cancer Res. 2017 Jan 13;19(1):6. doi: 10.1186/s13058-016-0799-9. Breast Cancer Res. 2017. PMID: 28086982 Free PMC article.
-
Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.Breast Cancer Res. 2011 Jan 26;13(1):R10. doi: 10.1186/bcr2817. Breast Cancer Res. 2011. PMID: 21269472 Free PMC article.
-
Reproductive and exogenous hormone factors in relation to risk of meningioma in women: a meta-analysis.PLoS One. 2013 Dec 27;8(12):e83261. doi: 10.1371/journal.pone.0083261. eCollection 2013. PLoS One. 2013. PMID: 24386167 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical